Metformine Bgr

Metformin Hydrochloride, the active ingredient in Metformine Bgr, is a biguanide presented as a tablet for oral use. It treats type 2 diabetes mellitus in adults.

GNH USA supplies Metformine Bgr as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Metformin Hydrochloride is used in the management of disorders related to glucose metabolism, primarily type 2 diabetes mellitus.

- Type 2 diabetes mellitus: improves glycemic control by lowering fasting and post‑prandial blood glucose levels. - Prediabetes: helps delay progression to overt diabetes by enhancing insulin sensitivity. - Polycystic ovary syndrome: used off‑label to improve insulin resistance and restore ovulatory function.

Metformin is associated with a range of adverse reactions, most of which are mild and reversible.

Common Side Effects: - Nausea: mild to moderate gastrointestinal upset. - Diarrhea: frequent loose stools, especially during treatment initiation. - Abdominal discomfort: cramping or bloating. - Metallic taste: transient alteration in taste perception. - Weight loss: modest reduction in body weight. - Vitamin B12 deficiency: gradual decrease with long‑term use.

Serious or Rare Side Effects: - Lactic acidosis: rare but life‑threatening metabolic acidosis. - Severe hypoglycemia: when combined with insulin or sulfonylureas. - Hepatic dysfunction: elevated liver enzymes in susceptible individuals. - Skin rash or hypersensitivity: including Stevens‑Johnson syndrome. - Pancreatitis: inflammation of the pancreas. - Electrolyte imbalance: especially in renal impairment.

Metformin requires careful monitoring in several clinical situations.

- Renal function monitoring: assess creatinine clearance before initiation and periodically thereafter. - Hepatic assessment: evaluate liver enzymes in patients with existing liver disease. - Vitamin B12 surveillance: consider periodic testing during long‑term therapy. - Cardiovascular status: avoid in patients with unstable or acute heart failure. - Elderly patients: start at lower doses and monitor for accumulation. - Store at room temperature: keep in the original container, protect from moisture and heat.

Metformin may interact with a variety of medicines, altering its efficacy or safety.

Major Interactions (Avoid): - Iodinated contrast agents: increase risk of acute renal failure and lactic acidosis. - Alcohol: potentiates lactic acidosis, especially with chronic intake. - Cimetidine: can raise metformin plasma concentrations. - Certain antiretrovirals (e.g., didanosine): elevate risk of lactic acidosis.

Moderate Interactions (Monitor Closely): - Beta‑blockers: may mask hypoglycemia symptoms. - Diuretics: affect renal clearance, requiring dose adjustment. - ACE inhibitors/ARBs: monitor renal function and electrolytes. - Thyroid hormones: may influence glycemic control, requiring closer glucose monitoring.